Growing evidence indicates that structural cells play a crucial role in the
chronic inflammation of autoimmunity by their recruitment of chemokine-dep
endent cells. Members of the two functional classes of chemokines, inflamma
tory and homeostatic, seem to be involved in lymphocyte recruitment and sur
vival, and in establishing ectopic lymphoid structures in the target organs
of autoimmune diseases. Results from animal models suggest that chemokines
are reasonable therapeutic targets in autoimmunity.